Pharmaceutical group ยท India
Cipla
A group of 13 companies with 227 medicines in 10 countries.
Group structure
13 companies in 6 countries
Loading your pageโฆ
Loading your pageโฆ
Pharmaceutical group ยท India
A group of 13 companies with 227 medicines in 10 countries.
13 companies in 6 countries
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine of every company in the group, current ones first.
1โ25 of 227
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ABIRATERONA CIPLA 500 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG500 mg ยท Comprimido recubierto con pelรญcula | Abiraterone | Spain | Marketed | 2022 |
| acetato de icatibanto | Icatibant | Brazil | Authorised | 2023 |
| ALBUTEROL SULFATE0.09mg base/inh ยท Aerosol, metered | Salbutamol | United States | Marketed | 2020 |
| AMBRISENTAN10mg | 5mg ยท Tablet | Ambrisentan | United States | Marketed | 2019 |
| ANAGRELIDE HYDROCHLORIDE0.5mg base | 1mg base ยท Capsule | Anagrelide | United States | Marketed | 2005 |
| APIXABAN CIPLACompressa rivestita con film | Apixaban | Italy | Authorised | |
| Apixaban Cipla 2,5 mg filmomhulde tablettenFilmomhulde tablet | Apixaban | Netherlands | Authorised | 2024 |
| Apixaban Cipla 5 mg filmomhulde tablettenFilmomhulde tablet | Apixaban | Netherlands | Authorised | 2024 |
| Arquist 125 mikrograma po potisku, stlaฤeni inhalat, suspenzija*stlaฤeni inhalat, suspenzija | Fluticasonpropionaat | Croatia | Not marketed | 2020 |
| Arquist 250 mikrograma po potisku, stlaฤeni inhalat, suspenzija*stlaฤeni inhalat, suspenzija | Fluticasonpropionaat | Croatia | Not marketed | 2020 |
| ARVALTI 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG20 mg ยท Comprimido recubierto con pelรญcula | Tadalafil | Spain | Authorised | 2019 |
| ASERIFLU 50 MICROGRAMOS/250 MICROGRAMOS/INHALACION POLVO PARA INHALACION (UNIDOSIS)72,5 ยตg + 250 ยตg ยท Polvo para inhalaciรณn (unidosis) | Salmeterol, Fluticasone | Spain | Authorised | 2025 |
| ASERIFLU 50 MICROGRAMOS/500 MICROGRAMOS/INHALACION POLVO PARA INHALACION (UNIDOSIS)72,5 ยตg + 500 ยตg ยท Polvo para inhalaciรณn (unidosis) | Salmeterol, Fluticasone | Spain | Authorised | 2025 |
| BECLOMETASONE E FORMOTEROLO CIPLASoluzione pressurizzata per inalazione | Beclometasone, Formoterol | Italy | Authorised | |
| BEXAROTENE CIPLACapsula molle | Bexarotene | Italy | Authorised | |
| BEXAROTENO CIPLA 75 MG CAPSULAS BLANDAS EFG75 mg ยท Cรกpsula blanda | Bexarotene | Spain | Marketed | 2021 |
| BIBECFOSoluzione pressurizzata per inalazione | Beclometasone, Formoterol | Italy | Authorised | |
| BIBECFO 100 MICROGRAMOS/6 MICROGRAMOS/PULSACION SOLUCION PARA INHALACION EN ENVASE A PRESION6 ยตg + 100 ยตg ยท Soluciรณn para inhalaciรณn en envase a presiรณn | Formoterol, Beclometasone | Spain | Marketed | 2024 |
| BIBECFO 200 MICROGRAMOS/6 MICROGRAMOS/PULSACION SOLUCION PARA INHALACION EN ENVASE A PRESION200 ยตg + 6 ยตg ยท Soluciรณn para inhalaciรณn en envase a presiรณn | Beclometasone, Formoterol | Spain | Marketed | 2024 |
| BORTECIP | Bortezomib | Brazil | Authorised | 2022 |
| BOSENTAN CIPLA 125 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG129,080 mg ยท Comprimido recubierto con pelรญcula | Bosentan | Spain | Marketed | 2016 |
| Bosentan Cipla 125 mg filmom obloลพene tablete*filmom obloลพena tableta | Bosentan | Croatia | Not marketed | 2020 |
| BOSENTAN CIPLA 62,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG64,540 mg ยท Comprimido recubierto con pelรญcula | Bosentan | Spain | Marketed | 2016 |
| Bosentan Cipla 62,5 mg filmom obloลพene tablete*filmom obloลพena tableta | Bosentan | Croatia | Not marketed | 2020 |
| BUDESONIDA/FORMOTEROL CIPLA 160 MICROGRAMOS/4,5 MICROGRAMOS/INHALACION POLVO PARA INHALACION (UNIDOSIS)Igual a 194.7 ยตg ยตg + Igual a 6.1 ยตg ยตg ยท Polvo para inhalaciรณn (unidosis) | Budesonide, Formoterol | Spain | Marketed | 2018 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Spain | 97 | 60 | 37 | CompaniesAll medicines |
| United States | 42 | 18 | 24 | CompaniesAll medicines |
| Brazil | 23 | 18 | 5 | CompaniesAll medicines |
| Netherlands | 18 | 18 | 0 | CompaniesAll medicines |
| Saudi Arabia | 16 | 16 | 0 | CompaniesAll medicines |
| Italy | 14 | 14 | 0 | CompaniesAll medicines |
| Croatia | 13 | 13 | 0 | CompaniesAll medicines |
| European Union (EMA) | 2 | 0 | 2 | CompaniesAll medicines |
| Canada | 1 | 0 | 1 | CompaniesAll medicines |
| Romania | 1 | 0 | 1 | CompaniesAll medicines |
Also in the registers of France, Singapore, United Kingdom
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
Fuente de la informaciรณn: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Source: BDPM (ANSM, HAS, UNCAM).
Licence: Licence Ouverte v1.0
ANVISA / CMED, consumer price table; embedded source date 2026-07-21 and retrieval date
Licence: Other (Public Domain)
Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.
Licence: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Fuente de la informaciรณn: Agencia Espaรฑola de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la informaciรณn: Agencia Espaรฑola de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Licence: BDPM exact Licence Ouverte v1.0 (October 2011)
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
GLEIF; exact source URLs/locators, version status and retrieval dates. Normalized by Prognia; no official endorsement.
Licence: CC0
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Ministerul Sฤnฤtฤศii, Catalogul public naลฃional al preลฃurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Contains information from ACRA Information on Corporate Entities, accessed on 8 October 2026 through Data.gov.sg, under Singapore Open Data Licence version 1.0: https://data.gov.sg/open-data-licence. Structured selection and normalisation by Prognia; original UEN, field and retrieval date retained.
Licence: Singapore Open Data Licence
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence: Singapore Open Data Licence
Report an error or request removalCorrections from the company itself are welcome.
Ranked by their number of medicines.